Adverum Biotechnologies' Grant

Adverum Biotechnologies raised a round of funding on October 01, 2012. Investors include National Eye Institute.

Adverum Biotechnologies, formerly Avalanche Biotechnologies, is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases.…

Articles about Adverum Biotechnologies' Grant: